Cybersecurity Expectations for Connected Medical Devices
A medical device that transmits data, connects to a hospital network, or receives remote software updates carries a risk profile that a purely mechanical product does not. Cybersecurity for these devices is no longer treated as an IT department's concern layered on top of the product; regulators now expect it to be designed in and documented as part of the device itself. For distributors and institutional buyers, understanding what that expectation actually covers helps in evaluating whether a manufacturer's connected product is genuinely supportable over its working life.
Why Connectivity Changes the Risk Profile
A device that only operates in isolation has a limited attack surface. Once it connects to a network, exchanges data with another system, or accepts firmware updates, it inherits exposure to the same categories of threat that affect any networked computer: unauthorized access, data interception, and malicious code. The clinical consequence can be more serious than a typical IT breach, because a compromised device may affect patient data, device function, or both. This is why connected medical devices (infusion pumps, imaging systems, monitors, diagnostic software, and similar products) now sit under cybersecurity expectations that did not meaningfully exist a decade ago.
What Premarket Documentation Now Includes
Regulators increasingly expect cybersecurity to be addressed before a device reaches market, not patched in afterward. In practice, this means manufacturers are expected to produce a threat model for the device, evidence of security testing performed during development, and a plan for how vulnerabilities discovered after launch will be identified, assessed, and remediated. Standards in the IEC 62443 family are commonly referenced for industrial and networked system security, alongside device-specific regulatory guidance that varies by market. Buyers should expect this documentation to exist as part of a device's technical file, not be produced only on request after a concern is raised.
The Software Bill of Materials
An increasingly common artifact is the software bill of materials (SBOM), a structured list of the software components, including third-party and open-source libraries, that make up a device's software. An SBOM matters because most security vulnerabilities are disclosed against specific software components, not against a finished device. Without an SBOM, a manufacturer (and by extension a distributor or hospital IT team) cannot quickly determine whether a newly disclosed vulnerability actually affects a given product. Its absence is a meaningful gap in a supplier's security posture.
Lifecycle Management, Not a One-Time Check
Cybersecurity support for a connected device does not end at launch. Mature manufacturers publish a defined support lifecycle: how long security patches will be issued, how patches are validated and distributed, and what happens when a product reaches end-of-support. A device still in clinical use after its manufacturer has stopped issuing security updates carries risk that grows over time, independent of how well it was designed initially. This is a lifecycle commitment, not a one-time certification, and it is worth confirming before committing to a long equipment lifecycle.
What Buyers Should Ask
| Question | Why it matters | |---|---| | Is there a documented SBOM for the device's software? | Shows whether vulnerability exposure can be assessed quickly when one is disclosed. | | What is the committed patch and support timeline? | Clarifies how long security updates will continue after purchase. | | How are vulnerabilities disclosed and reported to customers? | A credible process names a point of contact and a disclosure timeline. | | Can the device be segmented on the network? | Network segmentation limits how far a compromise elsewhere can reach. |
The Takeaway
Cybersecurity for networked medical devices is now a lifecycle commitment, not a one-off technical checkbox. Distributors and institutional buyers who ask about threat modeling, software bills of materials, patch timelines, and disclosure processes before purchase are better positioned to support these devices safely for as long as they remain in clinical use.
This is general educational information, not legal or regulatory advice; consult the current official texts and your competent authority.